MILLICENT JENKINS: Open Payments
NPI 1770723579 · NORTH AUGUSTA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$403 in 6 payments from 4 companies in 2025. Trend: 2023 $164 · 2024 $153 · 2025 $403
Food & beverage: $403
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 1 | $137 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $122 |
| Lilly USA, LLC | 1 | $98 |
| ABBVIE INC. | 3 | $46 |
Products named: REXULTI, CAPLYTA, ZEPBOUND, QULIPTA, UBRELVY.
Industry payments across SC — which companies pay providers there.
